Amia Capital LLP Cidara Therapeutics, Inc. Transaction History

Amia Capital LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$1.99 - $3.25 $30,661 - $50,076	-15,408 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$2.85 - $4.1 $1,878 - $2,701	-659 Reduced 4.1%	15,408 $44,000
Q2 2020 Aug 14, 2020	SELL	$2.39 - $4.0 $16,720 - $27,984	-6,996 Reduced 30.33%	16,067 $59,000
Q1 2020 May 15, 2020	BUY	$1.74 - $4.26 $40,129 - $98,248	23,063 New	23,063 $57,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.42B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.